SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Reducing the Burden of MS Treatment
Multiple Sclerosis Physician Resources
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Optimizing MS Treatment Options
Immunologic Effects on Metabolic Syndrome and MS
Highlights from the MAGNIMS Consensus Guidelines
Establishing Partnerships to Optimize Patient Outcomes
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Determining an MS Patient's Long-Term Prognosis
Current Landscape of MS Diagnosis/Prognosis
The Value of Biomarkers in MS Patients
Current and Future MS Treatment Options
Emerging MRI Techniques in MS Patients
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.
